Reduced apolipoprotein E-rich high-density lipoprotein level at birth is restored to the normal range in patients with familial hypercholesterolemia in the first year of life
- PMID: 18182454
- DOI: 10.1210/jc.2007-1621
Reduced apolipoprotein E-rich high-density lipoprotein level at birth is restored to the normal range in patients with familial hypercholesterolemia in the first year of life
Abstract
Background: High-density lipoprotein (HDL) consists of apolipoprotein E (apoE)-rich and apoE-poor HDL particles. ApoE-rich HDL level is high at birth but decreases after birth with reciprocal elevation in low-density lipoprotein (LDL)-cholesterol.
Objectives: The objective of the study was to clarify whether apoE-rich HDL decreases after birth in children with familial hypercholesterolemia (FH), a disorder caused by impaired LDL clearance.
Methods: We measured apoE-rich HDL-cholesterol and LDL-cholesterol during the first year of life in 10 FH children (one homozygote and nine heterozygotes), 12 non-FH siblings, and 75 healthy controls.
Results: At birth, apoE-rich HDL-cholesterol was undetectable in a homozygous FH child and lower in heterozygous FH children than non-FH siblings and controls (4+/-2 vs. 12+/-4 and 11+/-4 mg/dl, P<0.001). At 3-4 months, apoE-rich HDL-cholesterol increased in homozygous and heterozygous FH children and decreased in non-FH siblings and controls. At 12 months, apoE-rich HDL-cholesterol levels were similar among these four groups (6-7 mg/dl). In contrast, LDL-cholesterol concentration was always twice as high in heterozygous FH children as non-FH siblings and controls (at birth, 50+/-15 vs. 25+/-7 and 25+/-5 mg/dl, P<0.001; at 3-4 months of age, 159+/-29 vs. 71+/-16 and 73+/-15 mg/dl, P<0.001; at 12 months of age, 156+/-29 vs. 75+/-18 and 76+/-17 mg/dl, P<0.001).
Conclusion: ApoE-rich HDL level is low at birth in FH children and increases to the normal level in the first year of life, opposite to the change in normal children.
Similar articles
-
Serum apolipoproteins in heterozygous familial hypercholesterolemia.Clin Chim Acta. 1992 Oct 15;211(1-2):93-9. doi: 10.1016/0009-8981(92)90108-3. Clin Chim Acta. 1992. PMID: 1468157
-
HDL cholesterol levels in patients with molecularly defined familial hypercholesterolemia.Ann Clin Lab Sci. 2002 Winter;32(1):50-4. Ann Clin Lab Sci. 2002. PMID: 11848618
-
Determinants of lipid level variability in French-Canadian children with familial hypercholesterolemia.Arterioscler Thromb Vasc Biol. 2001 Jun;21(6):979-84. doi: 10.1161/01.atv.21.6.979. Arterioscler Thromb Vasc Biol. 2001. PMID: 11397707
-
The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.Dan Med Bull. 2002 Nov;49(4):318-45. Dan Med Bull. 2002. PMID: 12553167 Review.
-
Decreasing the Cholesterol Burden in Heterozygous Familial Hypercholesterolemia Children by Dietary Plant Stanol Esters.Nutrients. 2018 Dec 1;10(12):1842. doi: 10.3390/nu10121842. Nutrients. 2018. PMID: 30513705 Free PMC article. Review.
Cited by
-
An infant with a heterozygous variant of ABCG5 presented with hypercholesterolemia only during breastfeeding.Clin Pediatr Endocrinol. 2023;32(2):114-118. doi: 10.1297/cpe.2022-0075. Epub 2023 Feb 28. Clin Pediatr Endocrinol. 2023. PMID: 37020702 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous